Pseudohypoaldosteronism Type 2 Overview
Learn About Pseudohypoaldosteronism Type 2
Pseudohypoaldosteronism type 2 (PHA2) is caused by problems that affect regulation of the amount of sodium and potassium in the body. Sodium and potassium are important in the control of blood pressure, and their regulation occurs primarily in the kidneys.
PHA2 can be caused by mutations in the WNK1, WNK4, CUL3, or KLHL3 gene. These genes play a role in the regulation of blood pressure.
PHA2 is a rare condition; however, the prevalence is unknown.
This condition is usually inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In most cases caused by mutations in the WNK1, WNK4, or KLHL3 gene, an affected person inherits the mutation from one affected parent. While some cases caused by CUL3 gene mutations can be inherited from an affected parent, many result from new mutations in the gene and occur in people with no history of the disorder in their family.
Lake Forest Internal Medicine Ltd
Elliot Miller is an Internal Medicine provider in Libertyville, Illinois. Dr. Miller and is rated as an Experienced provider by MediFind in the treatment of Pseudohypoaldosteronism Type 2. His top areas of expertise are Type B Insulin Resistance Syndrome, Abdominal Obesity Metabolic Syndrome, Cytochrome C Oxidase Deficiency, and Mitochondrial Complex V Deficiency. Dr. Miller is currently accepting new patients.
Northwestern Medical Faculty Foundation
John Friedewald is a Nephrologist in Chicago, Illinois. Dr. Friedewald and is rated as an Experienced provider by MediFind in the treatment of Pseudohypoaldosteronism Type 2. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Acute Kidney Failure, Kidney Transplant, and Nephrectomy. Dr. Friedewald is currently accepting new patients.
Dean Health Systems Inc
Charles Stuart is a Nephrologist and a Hospital Medicine provider in Janesville, Wisconsin. Dr. Stuart and is rated as an Experienced provider by MediFind in the treatment of Pseudohypoaldosteronism Type 2. His top areas of expertise are Chronic Kidney Disease, Acute Kidney Failure, Nephrosclerosis, and Renovascular Hypertension. Dr. Stuart is currently accepting new patients.
Summary: Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple blood test, rare genetic conditions can be easily detected, and the early start of transformative treatment will help avoid severe disabilities and increase the quality of life. Baby Detect Project is an innovative NBS program using a pane...
Summary: The goal of this National Registry is to is to collect information from patients with rare kidney diseases, so that it that can be used for research. The purpose of this research is to: * Develop Clinical Guidelines for specific rare kidney diseases. These are written recommendations on how to diagnose and treat a medical condition. * Audit treatments and outcomes. An audit makes checks to see if ...
Published Date: March 01, 2016
Published By: National Institutes of Health